Skip to main content
Figure 3 | World Journal of Surgical Oncology

Figure 3

From: The efficacy of molecular subtyping in predicting postoperative recurrence in breast-conserving therapy: a 15-study meta-analysis

Figure 3

Forest plots for the recurrence risk of triple-molecular typing after BCT in the following comparisons: LB vs. LA (A), Her-2 vs. LA (B), TN vs. LA (C) and TN vs. non-TN (D). Squares and horizontal lines correspond to the study-specific HRs and 95% CIs, respectively. The area of the squares correlates the weight and the diamonds represent the summary HRs and 95% CIs. Begg's funnel plots for publication bias for the following comparisons: LB vs. LA (a), Her-2 vs. LA (b), TN vs. LA (c) and TN vs. non-TN (d). LB, Luminal B; LA, Luminal A; Her-2, human epidermal growth factor receptor 2; TN, triple-negative.

Back to article page